FWPAY — Forward Pharma A/S Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
- $0.03m
- -$70.74m
Annual balance sheet for Forward Pharma A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 110 | 82.5 | 77.6 | 79.1 | 70.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.935 | 0.448 | 0.273 | 0.287 | 0.14 |
Prepaid Expenses | |||||
Total Current Assets | 111 | 83.3 | 78.2 | 79.7 | 71.4 |
Net Property, Plant And Equipment | 0.012 | 0 | — | — | — |
Other Long Term Assets | |||||
Total Assets | 111 | 83.3 | 78.2 | 79.7 | 71.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 21.3 | 1.12 | 0.596 | 1.07 | 0.608 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 21.3 | 1.12 | 0.596 | 1.07 | 0.608 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 89.7 | 82.2 | 77.6 | 78.6 | 70.8 |
Total Liabilities & Shareholders' Equity | 111 | 83.3 | 78.2 | 79.7 | 71.4 |
Total Common Shares Outstanding |